131 related articles for article (PubMed ID: 8377596)
1. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
2. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
4. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
Tsukahara K; Kanai S; Ohta M; Kitani K
Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
[TBL] [Abstract][Full Text] [Related]
5. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
6. Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis.
Boelsterli UA; Rakhit G; Balazs T
Hepatology; 1983; 3(1):12-7. PubMed ID: 6295906
[TBL] [Abstract][Full Text] [Related]
7. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity.
Miccio M; Orzes N; Lunazzi GC; Gazzin B; Corsi R; Tiribelli C
Biochem Pharmacol; 1989 Oct; 38(20):3559-63. PubMed ID: 2554925
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
Oliva L; Beaugé F; Choquart D; Montet AM; Guitaoui M; Montet JC
Alcohol Clin Exp Res; 1998 Oct; 22(7):1538-43. PubMed ID: 9802540
[TBL] [Abstract][Full Text] [Related]
9. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
Smith DJ; Gordon ER
J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Jacquemin E; Dumont M; Mallet A; Erlinger S
Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
[TBL] [Abstract][Full Text] [Related]
13. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
Accatino L; Pizarro M; Solís N; Koenig CS
Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
[TBL] [Abstract][Full Text] [Related]
14. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
Queneau PE; Bertault-Perès P; Mesdjian E; Durand A; Montet JC
Transplantation; 1993 Sep; 56(3):530-4. PubMed ID: 8212145
[TBL] [Abstract][Full Text] [Related]
15. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
16. [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis].
Shi QY; Kong BH; Ma KD; Zhang XL; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):680-2. PubMed ID: 14728856
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Micheline D; Emmanuel J; Serge E
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295
[TBL] [Abstract][Full Text] [Related]
18. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat.
Rodriguez JV; Torres AM; Lunazzi G; Tiribelli C
Biochem Pharmacol; 1992 Mar; 43(6):1289-93. PubMed ID: 1562282
[TBL] [Abstract][Full Text] [Related]
19. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
[TBL] [Abstract][Full Text] [Related]
20. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
Kanai S; Kitani K; Sato Y
J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
